Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-009706
Filing Date
2023-06-13
Accepted
2023-06-13 12:39:51
Documents
1
Period of Report
2023-06-12

Document Format Files

Seq Description Document Type Size
1 form4-06132023_040647.html 4  
1 form4-06132023_040647.xml 4 4154
  Complete submission text file 0001415889-23-009706.txt   5796
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Issuer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O IMMUNOMEDICS, INC. 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address
Islam Khalid (Reporting) CIK: 0001701858 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32295 | Film No.: 231010795